openPR Logo
Press release

AI in Drug Discovery Market Projected to Reach $26.5 Billion by 2034, Growing at a 29.8% CAGR

11-28-2024 10:16 AM CET | Health & Medicine

Press release from: Polaris Market Research & Consulting

AI in Drug Discovery Market

AI in Drug Discovery Market

๐“๐ก๐ž ๐€๐ˆ ๐ข๐ง ๐๐ซ๐ฎ๐  ๐๐ข๐ฌ๐œ๐จ๐ฏ๐ž๐ซ๐ฒ ๐ฆ๐š๐ซ๐ค๐ž๐ญ ๐ฌ๐ข๐ณ๐ž ๐ฐ๐š๐ฌ ๐ฏ๐š๐ฅ๐ฎ๐ž๐ ๐š๐ญ ๐”๐’๐ƒ ๐Ÿ,๐Ÿ—๐Ÿ’๐Ÿ•.๐Ÿ’๐Ÿ ๐ฆ๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐ข๐ง ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ’. ๐ˆ๐ญ ๐ข๐ฌ ๐ฉ๐ซ๐จ๐ฃ๐ž๐œ๐ญ๐ž๐ ๐ญ๐จ ๐ ๐ซ๐จ๐ฐ ๐ญ๐จ ๐”๐’๐ƒ ๐Ÿ๐Ÿ”,๐Ÿ’๐Ÿ—๐Ÿ•.๐Ÿ•๐Ÿ— ๐ฆ๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐›๐ฒ ๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ’, ๐ž๐ฑ๐ก๐ข๐›๐ข๐ญ๐ข๐ง๐  ๐š ๐œ๐จ๐ฆ๐ฉ๐จ๐ฎ๐ง๐ ๐š๐ง๐ง๐ฎ๐š๐ฅ ๐ ๐ซ๐จ๐ฐ๐ญ๐ก ๐ซ๐š๐ญ๐ž (๐‚๐€๐†๐‘) ๐จ๐Ÿ ๐Ÿ๐Ÿ—.๐Ÿ–% ๐Ÿ๐ซ๐จ๐ฆ ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ“ ๐ญ๐จ ๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ’.

๐Œ๐š๐ซ๐ค๐ž๐ญ ๐ƒ๐ž๐Ÿ๐ข๐ง๐ข๐ญ๐ข๐จ๐ง:
Advanced algorithms harness artificial intelligence (AI) in drug discovery to analyse large datasets, forecast molecular interactions, and create new compounds for potential therapy. By using machine learning and data mining methodologies, AI speeds up the drug development timeline, enhancing molecule choices and cutting expenses. It also improves target recognition, lead customization, and toxicity forecasting, transforming pharmaceutical research and speeding up the distribution of life-saving drugs.

๐†๐ž๐ญ ๐„๐ฑ๐œ๐ฅ๐ฎ๐ฌ๐ข๐ฏ๐ž ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐๐š๐ ๐ž๐ฌ ๐จ๐Ÿ ๐“๐ก๐ข๐ฌ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ:
https://www.polarismarketresearch.com/industry-analysis/ai-in-drug-discovery-market/request-for-sample

๐†๐ซ๐จ๐ฐ๐ญ๐ก ๐ƒ๐ซ๐ข๐ฏ๐ž๐ซ๐ฌ ๐š๐ง๐ ๐Ž๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐ž๐ฌ:
โ— Pharmaceutical companies are more frequently collaborating with AI technology providers to improve their drug discovery endeavors. These partnerships merge the pharmaceutical companies' industry knowledge with the AI technology's computational capabilities, resulting in streamlined drug development procedures and creative drug options.
โ— Ongoing progress in AI, especially in NLP, predictive analytics, and quantum computing, is greatly enhancing its potential in drug discovery. The merging of AI with genomics, proteomics, and other omics technologies is increasing the need for personalized medicines.

๐Š๐ž๐ฒ ๐๐ฅ๐š๐ฒ๐ž๐ซ๐ฌ:
With so many businesses involved, the market is projected to become more competitive as it continues to grow. Here is the list of the leading companies operating in the AI in drug
discovery market:

โ€ข Atomwise Inc.
โ€ข BenevolentAI
โ€ข Berg Health (In January 2023, Berg Health acquired by
BPGbio Inc.)
โ€ข BioSymetrics, Inc.
โ€ข CYCLICA (Acquired by Recursion Pharmaceuticals)
โ€ข Exscientia
โ€ข GNS Healthcare (In January 2023, the company
Rebranded as Aitia)
โ€ข Google (DeepMind)
โ€ข IBM
โ€ข Insilico Medicine
โ€ข Insitro

๐๐ฎ๐ฒ ๐๐จ๐ฐ ๐“๐ก๐ข๐ฌ ๐๐ซ๐ž๐ฆ๐ข๐ฎ๐ฆ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐‘๐ž๐ฉ๐จ๐ซ๐ญ๐ฌ:
https://www.polarismarketresearch.com/buy/802/0

๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ๐š๐ญ๐ข๐จ๐ง ๐Ž๐ฏ๐ž๐ซ๐ฏ๐ข๐ž๐ฐ:
The AI in drug discovery market is mainly segmented based on offering, technology, therapeutic area, application, end user, and region. Based on therapeutic area analysis, the oncology segment held the largest market share in 2024 because of the increasing number of cancer patients worldwide. The increase in cancer cases requires an expedited drug development process in the oncology field, leading to a rise in the usage of AI in drug discovery and subsequently boosting the growth of the market.

Moreover, according to the end user analysis, the pharmaceutical and biotechnology companies segment is anticipated to be the fastest-growing market segment because of the growing investment in research and development. These companies are notably ramping up their investments in research and development (R&D) in order to stay ahead of the competition and introduce new drugs to the market.

Artificial Intelligence in Drug Discovery Market, Application Outlook (Revenue - USD Million, 2020-2034)
โ€ข Drug Optimization & Repurposing
โ€ข Preclinical testing
โ€ข Others

Artificial Intelligence in Drug Discovery Market, Therapeutic Area Outlook (Revenue - USD Million, 2020-2034)
โ€ข Oncology
โ€ข Neurodegenerative Diseases
โ€ข Cardiovascular Disease
โ€ข Metabolic Diseases
โ€ข Infectious Disease
โ€ข Others

Artificial Intelligence in Drug Discovery Market, Offering Outlook (Revenue - USD Million, 2020-2034)
โ€ข Software
โ€ข Services

Artificial Intelligence in Drug Discovery Market, Technology Outlook (Revenue - USD Million, 2020-2034)
โ€ข Machine Learning
o Deep Learning
o Supervised Learning
o Reinforcement Learning
o Unsupervised Learning
o Other Machine Learning Technologies
โ€ข Other Technologies

Artificial Intelligence in Drug Discovery Market, End User Outlook (Revenue - USD Million, 2020-2034)
โ€ข Pharmaceutical & Biotechnology Companies
โ€ข Contract Research Organizations
โ€ข Research Centers
โ€ข Academic & Government Institutes

๐‚๐ฅ๐ข๐œ๐ค ๐ก๐ž๐ซ๐ž ๐ญ๐จ ๐€๐œ๐œ๐ž๐ฌ๐ฌ ๐ญ๐ก๐ž ๐…๐ฎ๐ฅ๐ฅ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ:
https://www.polarismarketresearch.com/industry-analysis/ai-in-drug-discovery-market
Geographical Landscape:

o North America (U.S., Canada)
o Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
o Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea)
o Latin America (Brazil, Mexico, Argentina)
o Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

๐Œ๐จ๐ซ๐ž ๐“๐ซ๐ž๐ง๐๐ข๐ง๐  ๐‹๐š๐ญ๐ž๐ฌ๐ญ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ๐ฌ ๐›๐ฒ ๐๐จ๐ฅ๐š๐ซ๐ข๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก:
Drug Device Combination Products Market
https://www.polarismarketresearch.com/industry-analysis/drug-device-combination-products-market

Lifestyle Diseases Apps Market
https://www.polarismarketresearch.com/industry-analysis/lifestyle-diseases-apps-market

Medical Billing Market
https://www.polarismarketresearch.com/industry-analysis/medical-billing-market

Sports Medicine Market
https://www.polarismarketresearch.com/industry-analysis/sports-medicine-market

North America SGLT2 Inhibitors Market
https://www.polarismarketresearch.com/industry-analysis/north-america-sglt2-inhibitors-market

๐‚๐จ๐ง๐ญ๐š๐œ๐ญ:

Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter

๐€๐›๐จ๐ฎ๐ญ ๐๐จ๐ฅ๐š๐ซ๐ข๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก & ๐‚๐จ๐ง๐ฌ๐ฎ๐ฅ๐ญ๐ข๐ง๐ , ๐ˆ๐ง๐œ:

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release AI in Drug Discovery Market Projected to Reach $26.5 Billion by 2034, Growing at a 29.8% CAGR here

News-ID: 3761470 • Views: โ€ฆ

More Releases from Polaris Market Research & Consulting

Granite Market Projected to Reach USD 6.63 Billion by 2034, Growing at a CAGR of 5.2%
Granite Market Projected to Reach USD 6.63 Billion by 2034, Growing at a CAGR of โ€ฆ
Polaris Market Research has released new insights into the Granite market, highlighting key developments, evolving trends, and growth prospects across major regions and segments. The report delivers an in-depth analysis of market dynamics, competitive shifts, and strategic outlooks to support informed decision-making for businesses and investors. Market at a Glance In 2024, the market was valued at USD 3.99 billion and is anticipated to grow to USD 6.63 Billion by 2034. Itโ€ฆ
Molecular Diagnostics for Sexually Transmitted Diseases Market to Reach USD 7.85 Billion by 2034, Growing at a CAGR of 7.5%
Molecular Diagnostics for Sexually Transmitted Diseases Market to Reach USD 7.85 โ€ฆ
Polaris Market Research announces the release of its latest study on the Molecular Diagnostics For Sexually Transmitted Diseases market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape. According to the findings, the market stood at 3.82 billion in 2024 and is expected toโ€ฆ
Higher Alpha Olefins Market Projected to Hit USD 20.01 Billion by 2034, Expanding at a CAGR of 6.8%
Higher Alpha Olefins Market Projected to Hit USD 20.01 Billion by 2034, Expandin โ€ฆ
Polaris Market Research announces the release of its latest study on the Higher Alpha Olefins market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape. According to the findings, the market stood at 10.39 billion in 2024 and is expected to reach 20.01 billionโ€ฆ
Direct Oral Anticoagulants (DOACs) Device Market to Reach USD 64.83 Billion by 2034, Growing at a CAGR of 7.44%
Direct Oral Anticoagulants (DOACs) Device Market to Reach USD 64.83 Billion by 2 โ€ฆ
Polaris Market Research announces the release of its latest study on the Direct Oral Anticoagulants (DOACs) Device market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape. According to the findings, the market stood at 31.67 billion in 2024 and is expected to reachโ€ฆ

All 5 Releases


More Releases for Drug

Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcomingโ€ฆ
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De โ€ฆ
Market Overview and Report Coverage Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeuticโ€ฆ
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric โ€ฆ
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights: * Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029 * Global and Regional Antibody Drug Conjugate Market Insight * Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023 * Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight * Insight On Antibody Drug Conjugates In Clinical Trials: > 550โ€ฆ
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application โ€ฆ
Market Study Report, LLC, has compiled an exhaustive research study of the โ€˜Alcohol Testing And Drug Testing Equipment marketโ€™, detailing every single market driver and intricately analyzing the business vertical. This โ€˜Alcohol Testing And Drug Testing Equipment marketโ€™ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drugโ€ฆ
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drugย Marketย From an insight perspective, the market report focuses on various levels of analyses โ€” industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.ย  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetesโ€ฆ
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymeraseโ€ฆ